Continuous administration of mirabegron has advantages in inhibition of central sensitization compared with short-term treatment cessation in a mouse model of overactive bladder.
Joonbeom KwonEun-Ju LeeHye-Ri ParkHyun-Jung ChoJi-Ae JangHyoungoh YangJihyun AnDonghwi ParkYeon-Joo KimKyung-Jae HurJae-Soo KimNaoki YoshimuraPublished in: Neurourology and urodynamics (2022)
Continuous mirabegron treatment seems to prevent central sensitization and, thus, might be desirable for long-term disease control of OAB.
Keyphrases